| PRINCIPAL
INVESTIGATOR:
Dr. John M. Angles
BVSc, BSc (Vet), DACVIM, DECVIM-CA
Ralston Purina Lecturer in Genetics and Medicine
Faculty of Veterinary Medicine
University College Dublin
Ballsbridge, Co Dublin 4 IRELAND
Phone: +353-1-668-7988, extension 2632
Fax: +353-1-667-5401
Email: john.angles@bigpond.com
ABSTRACT
Hypertrophic Osteodystrophy (HOD) is a common disease of the rapidly
growing dogs of the large and giant pure-breeds. Breeds found
to be at higher risk for HOD include the Great Dane, Weimaraner,
Irish Setter and German Shepherd. The disease in the Weimaraner
is particularly severe, with high mortality rates found in untreated
dogs. The age of onset is typically 8 to 16 weeks of age, with
males and females equally affected. Recent vaccination with multivalent
vaccines (<7 days) is a significant risk factor for occurrence
of disease. HOD in the Weimaraner is a genetic disease, with a
heritability of 0.35 and an autosomal recessive mode of inheritance.
Unfortunately, to date there is no method available to detect
carriers other than by test matings and this approach has been
ineffective in controlling the disease. DNA samples from 10 separate
3-4 generation families with HOD have been collected, and we propose
to identify a marker for susceptibility to HOD in the Weimaraner
breed. Determination of a genetic marker for HOD in the Weimaraner
will have immediate impact in the breed for genetic counselling.
An understanding on the pathogenesis of HOD and hyper-inflammatory
diseases in general may have broad implications for other breeds
with these diseases.
SPECIFIC OBJECTIVES OF THE STUDY:
Our primary objective is to identify a DNA marker for hypertrophic
osteodystrophy (HOD) in the Weimaraner breed. Locating a genetic
marker for HOD in the Weimaraner will have immediate impact in
the breed for genetic counselling.
BACKGROUND OF RESEARCH:
Hypertrophic Osteodystrophy (HOD) is a common disease of rapidly
growing, large to giant pure-breeds of dog. Most dogs present
with pain and lameness associated with swelling of the metaphyses
of the long bones. Fever and anorexia are also commonly associated
with clinical HOD (Muir, 1996). The Weimaraner breed unfortunately
has a severe form of HOD disease compared to most breeds, with
systemic manifestations including fever and multiple body organ
inflammation (Abeles, 1999; Angles and Pedersen, 2001). Diagnosis
of HOD relies on the typical signalment, clinical signs, and presence
of pathognomic radiographic changes in the metaphyses.
The cause of canine HOD remains unknown, with earlier speculations
of a vitamin C deficiency (Meier, 1957; Holmes, 1962) or over-nutrition
(Riser, 1965) largely discounted in more recent times (Grondalen,
1976). Expression of HOD disease has been linked to calcium content
of the diet, with Great Dane pups fed on a high calcium diet showing
HOD and those on a low calcium diet not showing disease (Goodman,
1998). However, Great Dane puppies from susceptible lines fed
on restricted calcium diets still show signs of HOD disease, albeit
with lesser severity (Great Dane Club of America, personal communication).
This suggests that calcium levels influence expression of the
inflammatory component of the disease but are not directly causative
for the disease. A similar effect has been seen in experimental
autoimmune encephalomyelitis (EAE) in mice, where low dietary
calcium led to protection against EAE (Cantorna, 1999).
There is mounting evidence that viral infection may be important
in the disease, with Distemper virus detected in the metaphyses
of dogs with HOD (Mee, 1992; Mee, 1993; Baumgartner, 1995). Several
authors (Abeles, 1999; Malik, 1995) have also noted a temporal
association with Distemper vaccination and onset of HOD disease.
However, to our knowledge no one has been able to experimentally
reproduce HOD with Distemper Virus infection, suggesting that
there are other important factors leading to expression of this
disease. In such a scenario, the Distemper virus would act as
a trigger for the initial immune response but expression of the
disease would depend on other immune regulatory factors.
The Weimaraner dog is heavily represented in case reports of
HOD in the veterinary literature, with documented familial clustering
(Grondalen, 1976; Woodard, 1982; Abeles, 1999). In a recent study
looking at breed predilection for developmental orthopedic diseases,
the Weimaraner was found to be 21 times more likely to develop
HOD compared to mixed breed dogs (Munjar, 1998). Similarly, the
Great Dane (190x), the Boxer (18.4x), the Irish Setter (14.3x),
and the German Shepherd (9.5x), were at increased risk for HOD.
Our work has confirmed that HOD in the Weimaraner is a genetic
disease, with a heritability of 0.35 and an autosomal recessive
mode of inheritance (Angles and Famula, 2001).
PRELIMINARY STUDIES:
The Weimaraner is at high risk for HOD disease compared to most
breeds. Using the Veterinary Medical Database (VMDB) at Purdue,
the Weimaraner is 16.4 times more likely to develop HOD compared
to the pooled population (Angles, unpublished data). Other breeds
at high risk included the Great Dane (23.1), Irish Setter (10.4)
and Irish Wolfhound (11.4). To date, the Weimaraner DNA-disease
database contains information for 70 Weimaraners that have been
diagnosed with HOD. Criteria for diagnosis of HOD are strict,
and include presence of appropriate clinical signs (swollen painful
metaphyses; fever; lameness), radiographic evidence of HOD, and
exclusion of other "look alike" diseases. Males and
females are equally affected, and the age of onset is typically
8 to 16 weeks of age (Angles and Pedersen, 2001). An important
finding of our studies has been the association of the HOD disease
with recent vaccination. In our cohort of Weimaraners in North
American, 80% of the dogs diagnosed with HOD had received a multivalent
vaccination within 7 days of disease onset (most within 2 to 3
days). The vaccine is probably not the cause for disease but acts
as a trigger for expression of HOD disease on a susceptible genetic
background.
The genetics of Hypertrophic osteodystrophy (HOD) in the Weimaraner
have been studied in AKC (CHF) grant # 1628. The mode of inheritance
of HOD in the Weimaraner is autosomal recessive based on retrospective
analysis of over 80 HOD affected Weimaraners and their extended
families (Angles and Famula, 2001). Based on a conservative estimate
of 2.8% for the prevalence of HOD in the Weimaraner (Angles, unpublished
data), some 30% of the breed are believed to be carriers for this
debilitating disease. DNA samples for 70 HOD affected Weimaraners
are available, and pedigree analyses have identified ten 3-4 generation
informative families segregating HOD disease. DNA samples are
stored at the University College Dublin and are freely available
for collaboration with other investigators by petition to the
principal investigator.
RESEARCH DESIGN:
DNA samples for the ten informative families are already available
for marker analysis at the University College Dublin. Based on
pedigree and preliminary marker analysis, we believe that a classical
linkage study will be the appropriate approach to analyzing these
families.
The minimum mapping set of 172 microsatellite markers available
through Research Genetics will be used to attain 15cM coverage
of the chromosomes to look for linkage. Some of the markers available
in the minimum mapping set are already available in multiplex
sets of markers at UCDavis. Preliminary data on these multiplex
sets suggests that some 25 markers will need replacement to ensure
even chromosome coverage for the Weimaraner breed.
Markers will initially be run across three pools of samples (i.e.
known affected, known carriers and "probable" clears)
looking for areas homozygous in known affected and heterozygous
in known carrier animals. This will allow us to increase the marker
saturation at an early stage in areas of potential interest. Marker
analysis will then be completed in the linkage families.
EXPECTED OUTCOME, SIGNIFICANCE AND
APPLICATION OF RESEARCH:
Our primary objective is to identify a DNA marker for hypertrophic
osteodystrophy (HOD) in the Weimaraner breed. Locating a genetic
marker for HOD in the Weimaraner will have immediate impact in
the breed for genetic counselling. For the first time, breeders
will be able to perform selective breeding to decrease the prevalence
of carriers and thereby disease in the breed. Twenty years of
selection based on test matings has unfortunately not been able
to achieve this objective.
Detection of a DNA marker for HOD in one breed will be critical
for furthering our knowledge on the pathogenesis of HOD disease.
Knowledge of the physical location of the DNA marker on the canine
chromosome may permit rapid identification of a candidate gene
for HOD disease susceptibility across many breeds. The Weimaraner
breed will give us the potential to dissect complex environmental
influences from underlying genetic risk factors to determine if
there is a common cause for HOD in the dog. The benefits for all
pure-breeds of dog will significant.
LITERATURE CITED:
1.Abeles, V, Harrus, S, Angles, JM, Shalev, G, Aizenberg, I, Peres,
Y and Aroch, I (1999) Hypertrophic osteodystrophy in six Weimaraner
puppies associated with systemic signs. Vet Record, 145: 130-134
2.Angles, JM and Pedersen, NC (2001) Hypertrophic
Osteodystrophy (HOD) in the Weimaraner: 60 cases. JAAHA (in preparation)
3.Angles, JM and Famula, TR (2001) Genetics
of Hypertrophic Osteodystrophy (HOD) in the Weimaraner. JVIM (in
preparation)
4.Baumgartner, W, Boyce, RW, Alldinger, S, Axthelm,
MK, Weisbrode, SE, Krakowka, S and Gaedke, K (1995) Metaphyseal
bone lesions in young dogs with systemic distemper virus infection.
Vet Microbiol, 44: 201-209
5.Cantorna, MT, Humpal-Winter, J, and DeLuca,
HF. (1999) Dietary Calcium is a Major Factor in 1, 25-Dihydroxychlecalciferol
Suppression of Experimental Autoimmune Encephalomyelitis in Mice.
J Nutr, 129: 1966-1971
6.Dougherty, SA, Center, SA, Shaw, EE and Erb,
HA (1991) Juvenile-onset polyarthritis syndrome in Akitas. JAVMA,
198 (5): 849-856
7.Goodman, SA, Montgomery, RD, Fitch, RB, Hathcock,
JT, et al (1998) Serial Orthopedic Examinations of Growing Great
Dane Puppies Fed Three Diets Varying in Calcium and Phosphorus.
In Recent Advances in Canine and Feline Nutrition, volume II.
Reinhart, GA and Carey, DP. (Eds) Iams Nutritional Symposium proceedings.
Pp. 3-12
8.Grondalen, J (1976) Metaphyseal osteopathy
(hypertrophic osteodystrophy) in growing dogs. A clinical study.
JSAP, 17: 721-735
9.Holmes, JR (1962) Suspected skeletal scurvy
in the dog. Vet Rec, 74: 801-813
10. Malik, R, Dowden, M, Davis, PE, Allan, GS,
Barrs, VR, Canfield, PJ and Love, DN. (1995) Concurrent Juvenile
Cellulitis and Metaphyseal Osteopathy: An Atypical Canine Distemper
Virus Syndrome? Aust Vet Pract, 25 (2): 62-67
11. Meier, H, Clark, ST, Schnelle, GB, Will,
DH (1957) Hypertrophic osteodystrophy associated with disturbance
of vitamin C synthesis in dogs. JAVMA, 130: 483-494
12. Mee, AP, Gordon, MT, May, C, Bennett, D,
Anderson, DC and Sharpe, PT (1992) Canine Distemper Virus Transcripts
Detected in the Bone Cells of Dogs with Metaphyseal Osteopathy.
Bone, 14: 59-67
13. Mee, AP, Webber, DM, May, C, Bennett, D,
Sharpe, PT and Anderson, DC (1993) Detection of Canine Distemper
Virus in Bone Cells in the Metaphyses of Distemper-infected Dogs.
J Bone and Mineral Research, 7 (7): 829-834
14. Muir, P, Dubielzig, RR, Johnson, KA, Shelton,
GD (1996) Hypertrophic osteodystrophy and calvarial hyperostosis.
CCEPV, 18(2): 143-151
15. Munjar, TA, Austin, CC, and Breur, GJ (1998)
Comparison of Risk Factors for Hypertrophic Osteodystrophy, Craniomandibular
Osteopathy and Canine Distemper Virus Infection. Vet Comp Orthop
Traumatol, 11: 37-43
16. Parker, WM and Foster, RA (1996) Cutaneous
vasculitis in five Jack Russell Terriers. Vet Dermatology, 7:
109-115
17. Riser, WH, Shirer, JF (1965) Normal and
abnormal growth of the distal foreleg in large and giant dogs.
J Am Vet Radiol Soc, 6: 50-64
18. Scott-Moncrieff, JCR, Snyder, PW, Glickman,
LT, Davis, EL and Felsburg, PJ (1992) Systemic necrotizing vasculitis
in nine young Beagles. JAVMA, 201 (10): 1553-1558
19. Snyder, PW, Kazacos, EA, Scott-Moncrieff,
JC, HogenEsch, H, Carlton, WW, Glickman, LT and Felsburg, PJ (1995)
Pathological Features of naturally Occurring Juvenile Polyarteritis
in Beagle Dogs. Vet Pathol, 32: 337-345
20. Sorensen, D. A., Andersen, S., Gianola,
D., and Korsgaard, I. 1995. Bayesian inference in threshold models
using Gibbs sampling. Genetique, Seletion, Evolution. 27:229-249
21. Woodard, JC (1982) Canine hypertrophic osteodystrophy,
a study of the spontaneous disease in littermates. Vet Pathol,
19: 337-354 "--------------------------------------------------------------------------------
This material is copyright April, 16th 2001
by Dr. John M. Angles. No portion of this text may be reproduced
in any form or distributed by any method, whether for profit or
not, without the express written permission of Dr. John M. Angles.
|